ID	Description	GeneRatio	BgRatio	pvalue	p.adjust	qvalue	geneID	Count
hsa05322	Systemic lupus erythematosus	56/338	136/8388	3.5828540476211e-43	1.02111340357201e-40	9.39084903008056e-41	H2BC18/H2BC14/H2AC15/H2BC9/H3C11/H2AC12/H3C13/H4C5/H2AC11/H4C6/H2BC4/H2BC10/H2BC7/H2BC6/H4C3/H2AC4/H4C8/H2AC14/H3C14/H2AC8/H4C9/H2AC17/H2BC3/H2AC13/H2BC15/H2BC8/H3C1/H2AC21/H2AX/H3C7/H2BC5/H2BC11/H2AC19/H2BC12/H2BC13/H2AC18/H3C10/H4C13/H3C3/H2BC17/H4C4/H4C2/H2AC16/H3C2/H4C15/H2BC21/H4C12/H3C6/H4C11/H3C8/H3C12/H2AC20/H3C15/H4C14/TNF/H4C1	56
hsa05034	Alcoholism	62/338	187/8388	4.00673523657149e-41	5.70959771211437e-39	5.2509319679279e-39	H2BC18/H2BC14/H2AC15/H2BC9/H3C11/H2AC12/H3C13/H4C5/H2AC11/H4C6/H2BC4/H2BC10/H2BC7/H2BC6/H4C3/H2AC4/H4C8/H2AC14/H3C14/H2AC8/H4C9/PRKACA/H2AC17/H2BC3/H2AC13/H2BC15/H2BC8/H3C1/H2AC21/GNG8/H2AX/H3C7/H2BC5/H2BC11/H2AC19/H2BC12/H2BC13/H2AC18/H3C10/H4C13/H3C3/H2BC17/H4C4/H4C2/H2AC16/H3C2/H4C15/FOSB/H2BC21/H4C12/H3C6/GNB5/H4C11/H3C8/GRIN2C/H3C12/H2AC20/H3C15/H4C14/GRIN3B/H4C1/GNG3	62
hsa04613	Neutrophil extracellular trap formation	59/338	190/8388	2.87142648672649e-37	2.72785516239017e-35	2.50871998313999e-35	H2BC18/H2BC14/H2AC15/H2BC9/H3C11/H2AC12/H3C13/H4C5/H2AC11/H4C6/H2BC4/H2BC10/H2BC7/H2BC6/H4C3/ACTG1/H2AC4/H4C8/H2AC14/H3C14/H2AC8/H4C9/H2AC17/H2BC3/H2AC13/H2BC15/H2BC8/H3C1/H2AC21/PLCB4/H2AX/H3C7/H2BC5/H2BC11/H2AC19/H2BC12/H2BC13/H2AC18/H3C10/H4C13/H3C3/H2BC17/ITGB3/H4C4/H4C2/H2AC16/H3C2/H4C15/H2BC21/H4C12/H3C6/H4C11/H3C8/SELP/H3C12/H2AC20/H3C15/H4C14/H4C1	59
hsa05203	Viral carcinogenesis	34/338	204/8388	9.49530060842237e-13	6.76540168350094e-11	6.22192066183466e-11	H2BC18/H2BC14/H2BC9/JUN/H4C5/H4C6/H2BC4/H2BC10/H2BC7/H2BC6/H4C3/H4C8/HLA-A/H4C9/PRKACA/H2BC3/H2BC15/H2BC8/H2BC5/H2BC11/H2BC12/H2BC13/H4C13/IL6ST/H2BC17/H4C4/H4C2/H4C15/H2BC21/H4C12/H4C11/IRF7/H4C14/H4C1	34
hsa05202	Transcriptional misregulation in cancer	22/338	193/8388	9.46712123871344e-06	0.000539625910606666	0.000496276460724136	H3C11/H3C13/GADD45B/H3C14/H3C1/H3C7/FLI1/H3C10/H3C3/H3C2/GADD45G/H3C6/FOXO1/NTRK1/H3C8/MEIS1/MLF1/H3C12/CEBPA/CSF2/H3C15/MMP9	22
hsa04724	Glutamatergic synapse	14/338	115/8388	0.00020178853682975	0.00883340718078065	0.00812379829368193	GRM3/TRPC1/ADCY6/PRKACA/PLCB4/GNG8/HOMER1/LZTS3/GNB5/GRIN2C/PLA2G4B/GRIK5/GRIN3B/GNG3	14
hsa04217	Necroptosis	17/338	159/8388	0.000216960878124437	0.00883340718078065	0.00812379829368193	H2AC15/H2AC12/H2AC11/H2AC4/H2AC14/H2AC8/H2AC17/H2AC13/H2AC21/H2AX/H2AC19/H2AC18/H2AC16/H2AC20/PLA2G4B/TNF/MAPK10	17
hsa05131	Shigellosis	22/338	247/8388	0.000389057040409238	0.0138601570645791	0.0127467372449869	H3C11/JUN/H3C13/ACTG1/H3C14/H3C1/PLCB4/H3C7/H3C10/H3C3/H3C2/UBE2D1/H3C6/FOXO1/H3C8/H3C12/PFN4/SEPTIN12/CSF2/H3C15/TNF/MAPK10	22
hsa05412	Arrhythmogenic right ventricular cardiomyopathy	9/338	77/8388	0.00362400980706247	0.114760310556978	0.105541338240767	ACTG1/SLC8A3/ITGB3/CACNA2D3/ITGA9/GJA1/CTNNA3/SGCA/TCF7	9
hsa04970	Salivary secretion	10/338	93/8388	0.00408649044940067	0.116464977807919	0.107109065463239	ATP1B4/ADCY6/SLC12A2/PRKACA/PLCB4/GUCY1B1/ATP1B1/ADRB3/ADRB2/AQP5	10
hsa05414	Dilated cardiomyopathy	10/338	96/8388	0.00513110590334496	0.132942289313938	0.122262714826114	ADCY6/ACTG1/PRKACA/SLC8A3/ITGB3/CACNA2D3/ITGA9/TNF/SGCA/TGFB2	10
hsa04926	Relaxin signaling pathway	12/338	129/8388	0.00571679645820005	0.135773915882251	0.124866870008054	RLN3/JUN/ADCY6/PRKACA/PLCB4/GNG8/GNB5/PRKCZ/MMP9/MAPK10/GNG3/NOS2	12
hsa04930	Type II diabetes mellitus	6/338	46/8388	0.00983596729100917	0.190470499913475	0.175169545626797	SOCS1/MAFA/SOCS3/PRKCZ/TNF/MAPK10	6
hsa05410	Hypertrophic cardiomyopathy	9/338	90/8388	0.0100644767479246	0.190470499913475	0.175169545626797	ACTG1/SLC8A3/ITGB3/CACNA2D3/ACE/ITGA9/TNF/SGCA/TGFB2	9
hsa04928	Parathyroid hormone synthesis, secretion and action	10/338	106/8388	0.0101842099968446	0.190470499913475	0.175169545626797	ADCY6/SLC9A3R1/EGR1/PRKACA/PLCB4/HBEGF/NR4A2/FGFR1/MAFB/MMP24	10
hsa04390	Hippo signaling pathway	13/338	157/8388	0.0106930806968968	0.190470499913475	0.175169545626797	FZD9/ACTG1/PARD6B/ID1/FRMD6/AREG/PRKCZ/FZD8/WNT5A/CTNNA3/TGFB2/TPTEP2-CSNK1E/TCF7	13
hsa05030	Cocaine addiction	6/338	49/8388	0.0132811992100359	0.22265539852119	0.20476895376464	GRM3/JUN/PRKACA/FOSB/GRIN2C/GRIN3B	6
hsa05224	Breast cancer	12/338	147/8388	0.0154212802402054	0.2393890319932	0.22015833413225	JUN/FZD9/GADD45B/HEY2/GADD45G/FGF22/FGFR1/FZD8/WNT5A/DLL4/DLL1/TCF7	12
hsa04713	Circadian entrainment	9/338	97/8388	0.0159592687995466	0.2393890319932	0.22015833413225	ADCY6/RASD1/PRKACA/PLCB4/GNG8/GNB5/GUCY1B1/GRIN2C/GNG3	9
hsa04726	Serotonergic synapse	10/338	115/8388	0.0173748142337279	0.244052304020667	0.224446994279394	TRPC1/PRKACA/PLCB4/GNG8/CYP2C19/GNB5/KCNN2/PLA2G4B/TPH2/GNG3	10
hsa04961	Endocrine and other factor-regulated calcium reabsorption	6/338	53/8388	0.0190796998665933	0.244052304020667	0.224446994279394	ATP1B4/ADCY6/PRKACA/SLC8A3/PLCB4/ATP1B1	6
hsa04010	MAPK signaling pathway	20/338	302/8388	0.0196860231127642	0.244052304020667	0.224446994279394	HSPA2/HSPA1B/JUN/ERBB3/GADD45B/HSPA1A/PRKACA/DUSP10/GADD45G/FGF22/FGFR1/NTRK1/AREG/MAP3K9/CACNA2D3/DUSP2/PLA2G4B/TNF/MAPK10/TGFB2	20
hsa04924	Renin secretion	7/338	69/8388	0.0205497683686543	0.244052304020667	0.224446994279394	ADCY6/PRKACA/PLCB4/GUCY1B1/ADRB3/ACE/ADRB2	7
hsa04310	Wnt signaling pathway	13/338	171/8388	0.0205517729701614	0.244052304020667	0.224446994279394	JUN/FZD9/TLE4/PRKACA/PLCB4/RSPO1/FZD8/WNT5A/SOX17/MAPK10/PRICKLE2/TPTEP2-CSNK1E/TCF7	13
hsa05210	Colorectal cancer	8/338	86/8388	0.022146455135427	0.252469588543868	0.232188098051424	JUN/GADD45B/APPL1/GADD45G/AREG/MAPK10/TGFB2/TCF7	8
hsa03040	Spliceosome	12/338	157/8388	0.0245574859751212	0.269187827034982	0.247563320154056	HSPA2/HSPA1B/HSPA1A/RNVU1-7/RNU1-4/RNU4-2/RNU1-2/RNVU1-18/RNU6-8/RNU5D-1/RNVU1-4/RNU6-2	12
hsa04923	Regulation of lipolysis in adipocytes	6/338	58/8388	0.0284899763048952	0.298925873371827	0.274912437560794	ADCY6/PRKACA/ADRB3/ADRB2/NPY1R/PLAAT2	6
hsa04550	Signaling pathways regulating pluripotency of stem cells	11/338	143/8388	0.02936815598039	0.298925873371827	0.274912437560794	FZD9/IL6ST/ID1/ID4/FGFR1/MEIS1/FZD8/HOXA1/WNT5A/ESX1/TCF7	11
hsa04978	Mineral absorption	6/338	60/8388	0.0329811830116328	0.317814892990532	0.292284056711514	ATP1B4/SLC8A3/TRPM6/ATP1B1/STEAP2/STEAP1	6
hsa04912	GnRH signaling pathway	8/338	93/8388	0.0334541992621613	0.317814892990532	0.292284056711514	JUN/ADCY6/EGR1/PRKACA/PLCB4/HBEGF/PLA2G4B/MAPK10	8
hsa05145	Toxoplasmosis	9/338	112/8388	0.0365039352717506	0.329530362065582	0.303058393921809	HSPA2/HSPA1B/HSPA1A/SOCS1/IRGM/TNF/MAPK10/TGFB2/NOS2	9
hsa04213	Longevity regulating pathway - multiple species	6/338	62/8388	0.0379083861599317	0.329530362065582	0.303058393921809	HSPA2/HSPA1B/ADCY6/HSPA1A/PRKACA/FOXO1	6
hsa04024	cAMP signaling pathway	15/338	225/8388	0.0381561471865411	0.329530362065582	0.303058393921809	ATP1B4/JUN/ADCY6/PRKACA/CRHR2/ATP1B1/GRIN2C/HCN4/ADRB2/SSTR5/TIAM1/NPY1R/GLP1R/GRIN3B/MAPK10	15
hsa05217	Basal cell carcinoma	6/338	63/8388	0.0405389072103381	0.339811428086657	0.312513557132328	FZD9/GADD45B/GADD45G/FZD8/WNT5A/TCF7	6
hsa01522	Endocrine resistance	8/338	98/8388	0.0435971570969477	0.355005422075145	0.326486980966616	JUN/ADCY6/PRKACA/HBEGF/MMP9/DLL4/MAPK10/DLL1	8
hsa04933	AGE-RAGE signaling pathway in diabetic complications	8/338	100/8388	0.048166734239777	0.381319979398235	0.350687626482587	JUN/EGR1/PLCB4/FOXO1/PRKCZ/TNF/MAPK10/TGFB2	8
hsa04371	Apelin signaling pathway	10/338	139/8388	0.0538271334520215	0.398459489908982	0.36645027880826	ADCY6/EGR1/PRKACA/SLC8A3/PLCB4/GNG8/GNB5/KLF2/GNG3/NOS2	10
hsa05418	Fluid shear stress and atherosclerosis	10/338	139/8388	0.0538271334520215	0.398459489908982	0.36645027880826	JUN/ACTG1/ITGB3/GSTT2B/PRKCZ/GSTT2/MMP9/TNF/MAPK10/KLF2	10
hsa04974	Protein digestion and absorption	8/338	103/8388	0.0555876754206557	0.398459489908982	0.36645027880826	ATP1B4/SLC8A3/SLC7A8/ATP1B1/CELA2A/COL10A1/COL26A1/SLC36A2	8
hsa04742	Taste transduction	7/338	86/8388	0.0577806954635159	0.398459489908982	0.36645027880826	ADCY6/PRKACA/PLCB4/SCNN1A/ENTPD2/HCN4/TAS2R42	7
hsa04911	Insulin secretion	7/338	86/8388	0.0577806954635159	0.398459489908982	0.36645027880826	ATP1B4/ADCY6/PRKACA/PLCB4/ATP1B1/KCNN2/GLP1R	7
hsa05031	Amphetamine addiction	6/338	69/8388	0.0587203458813236	0.398459489908982	0.36645027880826	JUN/PRKACA/FOSB/ARC/GRIN2C/GRIN3B	6
hsa05216	Thyroid cancer	4/338	37/8388	0.0602121713821766	0.399080670788845	0.367021558731015	GADD45B/GADD45G/NTRK1/TCF7	4
hsa04611	Platelet activation	9/338	124/8388	0.0624340388515205	0.40440229710644	0.371915685981546	ADCY6/ACTG1/PRKACA/PLCB4/ITGB3/GUCY1B1/PRKCZ/PLA2G4B/TBXAS1	9
hsa05205	Proteoglycans in cancer	13/338	205/8388	0.0705097304091655	0.446561625924715	0.410688254313034	ERBB3/FZD9/ACTG1/PRKACA/HBEGF/ITGB3/FGFR1/TIAM1/FZD8/WNT5A/MMP9/TNF/TGFB2	13
hsa04380	Osteoclast differentiation	9/338	128/8388	0.0731655974661063	0.453308592996528	0.416893221259965	JUN/SOCS1/ITGB3/FOSB/SOCS3/TNFRSF11A/TNF/MAPK10/TGFB2	9
hsa05226	Gastric cancer	10/338	149/8388	0.0781191494522231	0.473701225401778	0.435647664358422	FZD9/GADD45B/GADD45G/ABCB1/FGF22/FZD8/WNT5A/CTNNA3/TGFB2/TCF7	10
hsa04520	Adherens junction	7/338	93/8388	0.0807056795328732	0.47647385613216	0.43819756298027	ACTG1/SNAI1/TJP1/FGFR1/HEG1/CTNNA3/TCF7	7
hsa04068	FoxO signaling pathway	9/338	131/8388	0.0819200664928978	0.47647385613216	0.43819756298027	GADD45B/PLK2/HOMER1/GADD45G/FOXO1/MAPK10/KLF2/TGFB2/TPTEP2-CSNK1E	9
hsa04971	Gastric acid secretion	6/338	76/8388	0.0852126630703301	0.483079483422744	0.444272544311222	ATP1B4/ADCY6/ACTG1/PRKACA/PLCB4/ATP1B1	6
hsa05207	Chemical carcinogenesis - receptor activation	13/338	212/8388	0.0864458022967015	0.483079483422744	0.444272544311222	CYP1B1/JUN/ADCY6/PRKACA/GSTT2B/FGF22/KLF5/MIRLET7I/ADRB3/ADRB2/GSTT2/DLL4/DLL1	13
hsa05215	Prostate cancer	7/338	97/8388	0.0958642012715831	0.511672236216741	0.470568372365535	NKX3-1/FGFR1/FOXO1/MMP9/KLK3/INSRR/TCF7	7
hsa04210	Apoptosis	9/338	136/8388	0.0978591890739332	0.511672236216741	0.470568372365535	JUN/GADD45B/ACTG1/SPTAN1/PTPN13/GADD45G/NTRK1/TNF/MAPK10	9
hsa00590	Arachidonic acid metabolism	5/338	61/8388	0.0983752049695776	0.511672236216741	0.470568372365535	CYP2C19/PLA2G4B/TBXAS1/GGT5/PLAAT2	5
hsa04750	Inflammatory mediator regulation of TRP channels	7/338	98/8388	0.0998847431311704	0.511672236216741	0.470568372365535	ADCY6/PRKACA/PLCB4/NTRK1/PLA2G4B/TRPM8/MAPK10	7
hsa04514	Cell adhesion molecules	10/338	157/8388	0.101779435500323	0.511672236216741	0.470568372365535	HLA-A/NLGN4X/CLDN5/LRRC4B/NCAM1/CD276/SELP/ITGA9/ESAM/SLITRK5	10
hsa04915	Estrogen signaling pathway	9/338	138/8388	0.104704314962593	0.511672236216741	0.470568372365535	HSPA2/HSPA1B/JUN/ADCY6/HSPA1A/PRKACA/PLCB4/HBEGF/MMP9	9
hsa02010	ABC transporters	4/338	45/8388	0.10631397087917	0.511672236216741	0.470568372365535	ABCC12/ABCB1/ABCC9/ABCA13	4
hsa04935	Growth hormone synthesis, secretion and action	8/338	120/8388	0.110863521209668	0.511672236216741	0.470568372365535	ADCY6/PRKACA/PLCB4/SOCS1/SOCS3/SSTR3/SSTR5/MAPK10	8
hsa04916	Melanogenesis	7/338	101/8388	0.112490664001751	0.511672236216741	0.470568372365535	ADCY6/FZD9/PRKACA/PLCB4/FZD8/WNT5A/TCF7	7
hsa04919	Thyroid hormone signaling pathway	8/338	121/8388	0.114812537167447	0.511672236216741	0.470568372365535	ATP1B4/ACTG1/PRKACA/DIO3/PLCB4/ITGB3/FOXO1/ATP1B1	8
hsa04972	Pancreatic secretion	7/338	102/8388	0.116871407428527	0.511672236216741	0.470568372365535	ATP1B4/TRPC1/ADCY6/SLC12A2/PLCB4/ATP1B1/CELA2A	7
hsa05142	Chagas disease	7/338	102/8388	0.116871407428527	0.511672236216741	0.470568372365535	JUN/PLCB4/ACE/TNF/MAPK10/TGFB2/NOS2	7
hsa05146	Amoebiasis	7/338	102/8388	0.116871407428527	0.511672236216741	0.470568372365535	PRKACA/PLCB4/SERPINB9/CSF2/TNF/TGFB2/NOS2	7
hsa04360	Axon guidance	11/338	182/8388	0.117042757558149	0.511672236216741	0.470568372365535	TRPC1/EFNB2/PARD6B/RND1/SEMA6C/SEMA4F/PRKCZ/WNT5A/CXCR4/SLIT2/SRGAP3	11
hsa00591	Linoleic acid metabolism	3/338	30/8388	0.118492517860719	0.511672236216741	0.470568372365535	CYP2C19/PLA2G4B/PLAAT2	3
hsa05225	Hepatocellular carcinoma	10/338	168/8388	0.140396017348143	0.581342142979088	0.534641527615117	FZD9/GADD45B/ACTG1/GADD45G/GSTT2B/FZD8/WNT5A/GSTT2/TGFB2/TCF7	10
hsa05110	Vibrio cholerae infection	4/338	50/8388	0.141248654604376	0.581342142979088	0.534641527615117	ACTG1/SLC12A2/PRKACA/TJP1	4
hsa04540	Gap junction	6/338	88/8388	0.143386354083952	0.581342142979088	0.534641527615117	ADCY6/PRKACA/PLCB4/TJP1/GUCY1B1/GJA1	6
hsa04530	Tight junction	10/338	169/8388	0.144244081670499	0.581342142979088	0.534641527615117	JUN/ACTG1/PARD6B/SLC9A3R1/PRKACA/CLDN5/TJP1/PRKCZ/TIAM1/MAPK10	10
hsa04913	Ovarian steroidogenesis	4/338	51/8388	0.148725671183689	0.581342142979088	0.534641527615117	CYP1B1/ADCY6/PRKACA/PLA2G4B	4
hsa04727	GABAergic synapse	6/338	89/8388	0.148905180482363	0.581342142979088	0.534641527615117	ADCY6/PRKACA/GNG8/GNB5/GNG3/HAP1	6
hsa04976	Bile secretion	6/338	89/8388	0.148905180482363	0.581342142979088	0.534641527615117	ATP1B4/ADCY6/PRKACA/ABCB1/ATP1B1/KCNN2	6
hsa04710	Circadian rhythm	3/338	34/8388	0.155819329310693	0.600114984507398	0.55190630154143	NFIL3/NPAS2/TPTEP2-CSNK1E	3
hsa04921	Oxytocin signaling pathway	9/338	154/8388	0.168702890873782	0.633673681031627	0.582769147098338	JUN/ADCY6/ACTG1/PRKACA/PLCB4/RGS2/GUCY1B1/CACNA2D3/PLA2G4B	9
hsa04020	Calcium signaling pathway	13/338	240/8388	0.171005964119637	0.633673681031627	0.582769147098338	ERBB3/PRKACA/SLC8A3/PLCB4/FGF22/FGFR1/NTRK1/TRDN/GRIN2C/ADRB3/ADRB2/CXCR4/NOS2	13
hsa04934	Cushing syndrome	9/338	155/8388	0.173214762537665	0.633673681031627	0.582769147098338	ADCY6/FZD9/RASD1/PRKACA/PLCB4/CRHR2/FZD8/WNT5A/TCF7	9
hsa00512	Mucin type O-glycan biosynthesis	3/338	36/8388	0.175692321662251	0.633673681031627	0.582769147098338	GALNT9/GALNT15/GALNT12	3
hsa01210	2-Oxocarboxylic acid metabolism	2/338	19/8388	0.176992559604559	0.633673681031627	0.582769147098338	IDH3A/GPT2	2
hsa04657	IL-17 signaling pathway	6/338	94/8388	0.17787331397379	0.633673681031627	0.582769147098338	JUN/FOSB/CSF2/MMP9/TNF/MAPK10	6
hsa04918	Thyroid hormone synthesis	5/338	75/8388	0.184231445312369	0.646052412265666	0.594153465019948	ATP1B4/ADCY6/PRKACA/PLCB4/ATP1B1	5
hsa04960	Aldosterone-regulated sodium reabsorption	3/338	37/8388	0.185881746686964	0.646052412265666	0.594153465019948	ATP1B4/SCNN1A/ATP1B1	3
hsa00480	Glutathione metabolism	4/338	57/8388	0.196490499302536	0.657819966497937	0.60497570326126	CHAC1/GSTT2B/GSTT2/GGT5	4
hsa05134	Legionellosis	4/338	57/8388	0.196490499302536	0.657819966497937	0.60497570326126	HSPA2/HSPA1B/HSPA1A/TNF	4
hsa05140	Leishmaniasis	5/338	77/8388	0.198270267575579	0.657819966497937	0.60497570326126	JUN/MARCKSL1/TNF/TGFB2/NOS2	5
hsa04350	TGF-beta signaling pathway	6/338	98/8388	0.202554671127656	0.657819966497937	0.60497570326126	ZFYVE16/ID1/ID4/LRRC32/TNF/TGFB2	6
hsa04925	Aldosterone synthesis and secretion	6/338	98/8388	0.202554671127656	0.657819966497937	0.60497570326126	ATP1B4/ADCY6/PRKACA/PLCB4/NR4A2/ATP1B1	6
hsa05213	Endometrial cancer	4/338	58/8388	0.204873548650594	0.657819966497937	0.60497570326126	GADD45B/GADD45G/CTNNA3/TCF7	4
hsa04612	Antigen processing and presentation	5/338	78/8388	0.205424480766022	0.657819966497937	0.60497570326126	HSPA2/HSPA1B/HSPA1A/HLA-A/TNF	5
hsa04330	Notch signaling pathway	4/338	59/8388	0.213359393963373	0.675638080884015	0.621362445577543	HEY2/TLE4/DLL4/DLL1	4
hsa04621	NOD-like receptor signaling pathway	10/338	186/8388	0.21741995506409	0.680930628497425	0.626229830086274	JUN/GBP5/PLCB4/GBP4/IRGM/NLRP12/IRF7/MEFV/TNF/MAPK10	10
hsa00220	Arginine biosynthesis	2/338	22/8388	0.221588043648409	0.686441222171703	0.63129774449032	GPT2/NOS2	2
hsa05171	Coronavirus disease - COVID-19	12/338	232/8388	0.225969235226654	0.687392524014521	0.632172625963493	JUN/HBEGF/IL6ST/RPL36A/F13B/SELP/RPL3L/ACE/F13A1/CSF2/TNF/MAPK10	12
hsa04015	Rap1 signaling pathway	11/338	210/8388	0.22671893774514	0.687392524014521	0.632172625963493	ADCY6/ACTG1/PARD6B/PLCB4/ITGB3/ID1/FGF22/FGFR1/PFN4/PRKCZ/TIAM1	11
hsa04022	cGMP-PKG signaling pathway	9/338	167/8388	0.231388619534298	0.694165858602893	0.638401842260832	ATP1B4/ADCY6/SLC8A3/PLCB4/RGS2/GUCY1B1/ATP1B1/ADRB3/ADRB2	9
hsa00900	Terpenoid backbone biosynthesis	2/338	23/8388	0.236664906888478	0.694507321770585	0.638715874869347	IDI1/IDI2	2
hsa04964	Proximal tubule bicarbonate reclamation	2/338	23/8388	0.236664906888478	0.694507321770585	0.638715874869347	ATP1B4/ATP1B1	2
hsa00380	Tryptophan metabolism	3/338	42/8388	0.238813043977254	0.694507321770585	0.638715874869347	CYP1B1/TPH2/ASMT	3
hsa04014	Ras signaling pathway	12/338	236/8388	0.243351970444125	0.700558702793692	0.644281133871207	PRKACA/GNG8/ETS1/FGF22/FGFR1/GNB5/NTRK1/TIAM1/PLA2G4B/MAPK10/GNG3/PLAAT2	12
hsa04062	Chemokine signaling pathway	10/338	192/8388	0.246307820843806	0.70125019768342	0.64491707930996	ADCY6/PRKACA/PLCB4/GNG8/GNB5/PRKCZ/TIAM1/CXCR4/GNG3/CXCR6	10
hsa00534	Glycosaminoglycan biosynthesis - heparan sulfate / heparin	2/338	24/8388	0.251793957064828	0.70125019768342	0.64491707930996	NDST3/HS3ST3B1	2
hsa05167	Kaposi sarcoma-associated herpesvirus infection	10/338	194/8388	0.256230357618294	0.70125019768342	0.64491707930996	JUN/HLA-A/GNG8/IL6ST/GNB5/IRF7/CSF2/MAPK10/GNG3/TCF7	10
hsa04012	ErbB signaling pathway	5/338	85/8388	0.257642834826855	0.70125019768342	0.64491707930996	JUN/ERBB3/HBEGF/AREG/MAPK10	5
hsa04962	Vasopressin-regulated water reabsorption	3/338	44/8388	0.2606691506576	0.70125019768342	0.64491707930996	ADCY6/AQP2/PRKACA	3
hsa04931	Insulin resistance	6/338	108/8388	0.268958933669812	0.70125019768342	0.64491707930996	SOCS3/FOXO1/PRKCZ/TNF/MAPK10/CPT1B	6
hsa04260	Cardiac muscle contraction	5/338	87/8388	0.273126986962237	0.70125019768342	0.64491707930996	ATP1B4/SLC8A3/TRDN/ATP1B1/CACNA2D3	5
hsa04261	Adrenergic signaling in cardiomyocytes	8/338	154/8388	0.281280925056863	0.70125019768342	0.64491707930996	ATP1B4/ADCY6/PRKACA/SLC8A3/PLCB4/ATP1B1/CACNA2D3/ADRB2	8
hsa00592	alpha-Linolenic acid metabolism	2/338	26/8388	0.282096450979856	0.70125019768342	0.64491707930996	PLA2G4B/PLAAT2	2
hsa00790	Folate biosynthesis	2/338	26/8388	0.282096450979856	0.70125019768342	0.64491707930996	MOCS1/TPH2	2
hsa04950	Maturity onset diabetes of the young	2/338	26/8388	0.282096450979856	0.70125019768342	0.64491707930996	MAFA/FOXA3	2
hsa05166	Human T-cell leukemia virus 1 infection	11/338	222/8388	0.283212193435402	0.70125019768342	0.64491707930996	JUN/ADCY6/HLA-A/EGR1/PRKACA/ETS1/CSF2/TNF/MSX2/MAPK10/TGFB2	11
hsa04664	Fc epsilon RI signaling pathway	4/338	68/8388	0.293261454148292	0.70125019768342	0.64491707930996	CSF2/PLA2G4B/TNF/MAPK10	4
hsa00514	Other types of O-glycan biosynthesis	3/338	47/8388	0.293882721968128	0.70125019768342	0.64491707930996	GALNT9/GALNT15/GALNT12	3
hsa04973	Carbohydrate digestion and absorption	3/338	47/8388	0.293882721968128	0.70125019768342	0.64491707930996	ATP1B4/PLCB4/ATP1B1	3
hsa04270	Vascular smooth muscle contraction	7/338	134/8388	0.295482786718405	0.70125019768342	0.64491707930996	ADCY6/PRKACA/PLCB4/RAMP1/GUCY1B1/ADM/PLA2G4B	7
hsa00601	Glycosphingolipid biosynthesis - lacto and neolacto series	2/338	27/8388	0.297219197515609	0.70125019768342	0.64491707930996	FUT6/B3GNT4	2
hsa04920	Adipocytokine signaling pathway	4/338	69/8388	0.302412902761781	0.70125019768342	0.64491707930996	SOCS3/TNF/MAPK10/CPT1B	4
hsa05204	Chemical carcinogenesis - DNA adducts	4/338	69/8388	0.302412902761781	0.70125019768342	0.64491707930996	CYP1B1/GSTT2B/CYP2C19/GSTT2	4
hsa05211	Renal cell carcinoma	4/338	69/8388	0.302412902761781	0.70125019768342	0.64491707930996	JUN/EGLN3/ETS1/TGFB2	4
hsa04725	Cholinergic synapse	6/338	113/8388	0.304017110720552	0.70125019768342	0.64491707930996	ADCY6/PRKACA/PLCB4/GNG8/GNB5/GNG3	6
hsa05032	Morphine addiction	5/338	91/8388	0.304635782946974	0.70125019768342	0.64491707930996	ADCY6/PRKACA/GNG8/GNB5/GNG3	5
hsa04080	Neuroactive ligand-receptor interaction	17/338	367/8388	0.31059179598859	0.70125019768342	0.64491707930996	S1PR5/RLN3/GRM3/TAC3/CRHR2/VGF/GRIN2C/ADRB3/SSTR3/ADRB2/SSTR5/ADM/NPY1R/TRH/GRIK5/GLP1R/GRIN3B	17
hsa04668	TNF signaling pathway	6/338	114/8388	0.311131826434518	0.70125019768342	0.64491707930996	JUN/SOCS3/CSF2/MMP9/TNF/MAPK10	6
hsa04670	Leukocyte transendothelial migration	6/338	114/8388	0.311131826434518	0.70125019768342	0.64491707930996	ACTG1/CLDN5/ESAM/CXCR4/MMP9/CTNNA3	6
hsa04917	Prolactin signaling pathway	4/338	70/8388	0.311596203284736	0.70125019768342	0.64491707930996	SOCS1/SOCS3/TNFRSF11A/MAPK10	4
hsa05120	Epithelial cell signaling in Helicobacter pylori infection	4/338	70/8388	0.311596203284736	0.70125019768342	0.64491707930996	JUN/HBEGF/TJP1/MAPK10	4
hsa04144	Endocytosis	12/338	251/8388	0.31248693019577	0.70125019768342	0.64491707930996	VPS37D/HSPA2/HSPA1B/FOLR3/PARD6B/HSPA1A/ZFYVE16/HLA-A/SH3GL3/PRKCZ/CXCR4/PSD2	12
hsa05323	Rheumatoid arthritis	5/338	93/8388	0.320596396434945	0.712169855446565	0.654959534648918	JUN/CSF2/TNFRSF11A/TNF/TGFB2	5
hsa04392	Hippo signaling pathway - multiple species	2/338	29/8388	0.32729578320142	0.712169855446565	0.654959534648918	FRMD6/TPTEP2-CSNK1E	2
hsa00565	Ether lipid metabolism	3/338	50/8388	0.327348249345614	0.712169855446565	0.654959534648918	PLA2G4B/LPCAT1/PLAAT2	3
hsa05144	Malaria	3/338	50/8388	0.327348249345614	0.712169855446565	0.654959534648918	SELP/TNF/TGFB2	3
hsa05218	Melanoma	4/338	72/8388	0.330034819846065	0.712575179213095	0.655332297780464	GADD45B/GADD45G/FGF22/FGFR1	4
hsa01523	Antifolate resistance	2/338	30/8388	0.342210302154327	0.733307790330701	0.674399408281974	FOLR3/TNF	2
hsa01230	Biosynthesis of amino acids	4/338	75/8388	0.357787812179635	0.760966615456687	0.699836333328588	ASNS/ALDOB/IDH3A/GPT2	4
hsa05417	Lipid and atherosclerosis	10/338	215/8388	0.366760791538474	0.763555430754331	0.702217182854399	HSPA2/HSPA1B/JUN/HSPA1A/PLCB4/IRF7/SELP/MMP9/TNF/MAPK10	10
hsa05133	Pertussis	4/338	76/8388	0.367042435134538	0.763555430754331	0.702217182854399	JUN/TNF/MAPK10/NOS2	4
hsa05212	Pancreatic cancer	4/338	76/8388	0.367042435134538	0.763555430754331	0.702217182854399	GADD45B/GADD45G/MAPK10/TGFB2	4
hsa04141	Protein processing in endoplasmic reticulum	8/338	171/8388	0.384383330410202	0.789075819254031	0.725687457042488	HSPA2/HSPA1B/HSPA1A/CKAP4/UBE2D1/WFS1/ERO1B/MAPK10	8
hsa00980	Metabolism of xenobiotics by cytochrome P450	4/338	78/8388	0.385526211320026	0.789075819254031	0.725687457042488	CYP1B1/GSTT2B/GSTT2/AKR7A3	4
hsa04723	Retrograde endocannabinoid signaling	7/338	148/8388	0.387616191914261	0.789075819254031	0.725687457042488	ADCY6/PRKACA/PLCB4/GNG8/GNB5/MAPK10/GNG3	7
hsa04340	Hedgehog signaling pathway	3/338	56/8388	0.393993298067028	0.796369432263142	0.732395156541172	PRKACA/KIF3A/TPTEP2-CSNK1E	3
hsa01212	Fatty acid metabolism	3/338	57/8388	0.404965675776167	0.812783222508504	0.747490387459344	ELOVL7/HTD2/CPT1B	3
hsa05163	Human cytomegalovirus infection	10/338	225/8388	0.421560250289492	0.840172526800736	0.772679442930317	ADCY6/HLA-A/PRKACA/PLCB4/GNG8/ITGB3/GNB5/CXCR4/TNF/GNG3	10
hsa04730	Long-term depression	3/338	60/8388	0.43750740304551	0.84708733796223	0.779038770646705	PLCB4/GUCY1B1/PLA2G4B	3
hsa05416	Viral myocarditis	3/338	60/8388	0.43750740304551	0.84708733796223	0.779038770646705	ACTG1/HLA-A/SGCA	3
hsa04218	Cellular senescence	7/338	156/8388	0.440853805570082	0.84708733796223	0.779038770646705	GADD45B/HIPK2/HLA-A/ETS1/GADD45G/FOXO1/TGFB2	7
hsa04728	Dopaminergic synapse	6/338	132/8388	0.441353729423733	0.84708733796223	0.779038770646705	PRKACA/PLCB4/GNG8/GNB5/MAPK10/GNG3	6
hsa00250	Alanine, aspartate and glutamate metabolism	2/338	37/8388	0.442863204759201	0.84708733796223	0.779038770646705	ASNS/GPT2	2
hsa05143	African trypanosomiasis	2/338	37/8388	0.442863204759201	0.84708733796223	0.779038770646705	PLCB4/TNF	2
hsa05330	Allograft rejection	2/338	38/8388	0.456565531735671	0.860302411010405	0.79119224502896	HLA-A/TNF	2
hsa04610	Complement and coagulation cascades	4/338	86/8388	0.45844204538378	0.860302411010405	0.79119224502896	A2M/SERPINE2/F13B/F13A1	4
hsa00561	Glycerolipid metabolism	3/338	62/8388	0.458827952538883	0.860302411010405	0.79119224502896	DGAT1/LPL/LIPC	3
hsa05165	Human papillomavirus infection	14/338	331/8388	0.465462510166578	0.862023701532709	0.792775260135345	FZD9/PARD6B/HEY2/HLA-A/SLC9A3R1/PRKACA/ITGB3/FOXO1/ITGA9/PRKCZ/FZD8/WNT5A/TNF/TCF7	14
hsa04910	Insulin signaling pathway	6/338	137/8388	0.477109946739544	0.862023701532709	0.792775260135345	PRKACA/SOCS1/SOCS3/FOXO1/PRKCZ/MAPK10	6
hsa04929	GnRH secretion	3/338	64/8388	0.479798681353268	0.862023701532709	0.792775260135345	TRPC1/PLCB4/KCNN2	3
hsa00430	Taurine and hypotaurine metabolism	1/338	16/8388	0.482466894027328	0.862023701532709	0.792775260135345	GGT5	1
hsa05033	Nicotine addiction	2/338	40/8388	0.483375869367799	0.862023701532709	0.792775260135345	GRIN2C/GRIN3B	2
hsa04211	Longevity regulating pathway	4/338	89/8388	0.485071624193011	0.862023701532709	0.792775260135345	ADCY6/PRKACA/APPL1/FOXO1	4
hsa04512	ECM-receptor interaction	4/338	89/8388	0.485071624193011	0.862023701532709	0.792775260135345	SV2A/ITGB3/SV2C/ITGA9	4
hsa04927	Cortisol synthesis and secretion	3/338	65/8388	0.490140920443687	0.862023701532709	0.792775260135345	ADCY6/PRKACA/PLCB4	3
hsa05321	Inflammatory bowel disease	3/338	65/8388	0.490140920443687	0.862023701532709	0.792775260135345	JUN/TNF/TGFB2	3
hsa05162	Measles	6/338	139/8388	0.491233112556763	0.862023701532709	0.792775260135345	HSPA2/HSPA1B/JUN/HSPA1A/IRF7/MAPK10	6
hsa05219	Bladder cancer	2/338	41/8388	0.496471747911247	0.862023701532709	0.792775260135345	HBEGF/MMP9	2
hsa00120	Primary bile acid biosynthesis	1/338	17/8388	0.503361087746722	0.862023701532709	0.792775260135345	CYP46A1	1
hsa00450	Selenocompound metabolism	1/338	17/8388	0.503361087746722	0.862023701532709	0.792775260135345	SCLY	1
hsa05332	Graft-versus-host disease	2/338	42/8388	0.509354683107947	0.862023701532709	0.792775260135345	HLA-A/TNF	2
hsa04720	Long-term potentiation	3/338	67/8388	0.510517969081339	0.862023701532709	0.792775260135345	PRKACA/PLCB4/GRIN2C	3
hsa05221	Acute myeloid leukemia	3/338	67/8388	0.510517969081339	0.862023701532709	0.792775260135345	CEBPA/CSF2/TCF7	3
hsa04658	Th1 and Th2 cell differentiation	4/338	92/8388	0.511164931786062	0.862023701532709	0.792775260135345	JUN/DLL4/MAPK10/DLL1	4
hsa04940	Type I diabetes mellitus	2/338	43/8388	0.522020534600625	0.867285028248676	0.797613931796567	HLA-A/TNF	2
hsa00061	Fatty acid biosynthesis	1/338	18/8388	0.523414122311482	0.867285028248676	0.797613931796567	HTD2	1
hsa00511	Other glycan degradation	1/338	18/8388	0.523414122311482	0.867285028248676	0.797613931796567	NEU1	1
hsa04071	Sphingolipid signaling pathway	5/338	121/8388	0.541800963741082	0.888807941132139	0.817407857218477	S1PR5/PLCB4/PRKCZ/TNF/MAPK10	5
hsa05130	Pathogenic Escherichia coli infection	8/338	197/8388	0.542640637743832	0.888807941132139	0.817407857218477	JUN/ACTG1/SLC9A3R1/CLDN5/TJP1/TNF/MYO5C/MAPK10	8
hsa04622	RIG-I-like receptor signaling pathway	3/338	71/8388	0.549942008564624	0.89561984251953	0.823672542150926	IRF7/TNF/MAPK10	3
hsa00982	Drug metabolism - cytochrome P450	3/338	72/8388	0.559503190682822	0.898439171917702	0.826265388024036	GSTT2B/CYP2C19/GSTT2	3
hsa05223	Non-small cell lung cancer	3/338	72/8388	0.559503190682822	0.898439171917702	0.826265388024036	GADD45B/GADD45G/ALK	3
hsa00100	Steroid biosynthesis	1/338	20/8388	0.561130430180179	0.898439171917702	0.826265388024036	TM7SF2	1
hsa04640	Hematopoietic cell lineage	4/338	99/8388	0.569550141434095	0.906825644182777	0.833978154760892	CD9/ITGB3/CSF2/TNF	4
hsa04810	Regulation of actin cytoskeleton	9/338	229/8388	0.579347338969114	0.917299953367764	0.843611037446254	ACTG1/ITGB3/FGF22/FGFR1/ITGA9/PFN4/TIAM1/CXCR4/INSRR	9
hsa05220	Chronic myeloid leukemia	3/338	76/8388	0.596498048587831	0.932674649778306	0.857750647441544	GADD45B/GADD45G/TGFB2	3
hsa00330	Arginine and proline metabolism	2/338	50/8388	0.604386020311783	0.932674649778306	0.857750647441544	SAT2/NOS2	2
hsa05100	Bacterial invasion of epithelial cells	3/338	77/8388	0.605425392781753	0.932674649778306	0.857750647441544	ACTG1/SEPTIN12/CTNNA3	3
hsa04064	NF-kappa B signaling pathway	4/338	104/8388	0.608794687889435	0.932674649778306	0.857750647441544	GADD45B/GADD45G/TNFRSF11A/TNF	4
hsa04620	Toll-like receptor signaling pathway	4/338	104/8388	0.608794687889435	0.932674649778306	0.857750647441544	JUN/IRF7/TNF/MAPK10	4
hsa04660	T cell receptor signaling pathway	4/338	104/8388	0.608794687889435	0.932674649778306	0.857750647441544	JUN/CSF2/TNF/MAPK10	4
hsa04614	Renin-angiotensin system	1/338	23/8388	0.612197561859303	0.932674649778306	0.857750647441544	ACE	1
hsa04979	Cholesterol metabolism	2/338	51/8388	0.615238014590602	0.932674649778306	0.857750647441544	LPL/LIPC	2
hsa05170	Human immunodeficiency virus 1 infection	8/338	212/8388	0.626514414647075	0.941800925710332	0.866143787633879	JUN/HLA-A/GNG8/GNB5/CXCR4/TNF/MAPK10/GNG3	8
hsa04977	Vitamin digestion and absorption	1/338	24/8388	0.627867283806888	0.941800925710332	0.866143787633879	LRAT	1
hsa04922	Glucagon signaling pathway	4/338	107/8388	0.631264846952263	0.941939693096308	0.866271407501314	PRKACA/PLCB4/FOXO1/CPT1B	4
hsa04659	Th17 cell differentiation	4/338	108/8388	0.638568934693438	0.947567532716854	0.871447149202204	JUN/IL6ST/IRF4/MAPK10	4
hsa05161	Hepatitis B	6/338	162/8388	0.641686083559133	0.947567532716854	0.871447149202204	JUN/IRF7/MMP9/TNF/MAPK10/TGFB2	6
hsa04146	Peroxisome	3/338	82/8388	0.648072696142059	0.952065558765396	0.875583837978148	PIPOX/MPV17L2/NOS2	3
hsa05135	Yersinia infection	5/338	137/8388	0.652445090960852	0.953573594481245	0.876970729550619	JUN/ACTG1/MEFV/TNF/MAPK10	5
hsa04814	Motor proteins	7/338	193/8388	0.666017198755687	0.961250201340989	0.88403065608091	ACTG1/KIF1B/KIF3A/STARD9/DNAH3/DYNLT3/MYO5C	7
hsa05020	Prion disease	10/338	273/8388	0.667633672871347	0.961250201340989	0.88403065608091	HSPA2/HSPA1B/HSPA1A/EGR1/PRKACA/NCAM1/GRIN2C/GRIN3B/TNF/MAPK10	10
hsa00062	Fatty acid elongation	1/338	27/8388	0.67118873707669	0.961250201340989	0.88403065608091	ELOVL7	1
hsa01040	Biosynthesis of unsaturated fatty acids	1/338	27/8388	0.67118873707669	0.961250201340989	0.88403065608091	ELOVL7	1
hsa05132	Salmonella infection	9/338	249/8388	0.679063458439727	0.96766542827661	0.889930532376273	RHOB/JUN/ACTG1/PODXL/DYNLT3/PFN4/TNF/MAPK10/TCF7	9
hsa04936	Alcoholic liver disease	5/338	142/8388	0.683326872947432	0.96889631238815	0.891062536600736	FOXO1/TNF/MAPK10/CPT1B/TCF7	5
hsa00020	Citrate cycle (TCA cycle)	1/338	30/8388	0.709480140607888	0.984896383253138	0.905777283213412	IDH3A	1
hsa00030	Pentose phosphate pathway	1/338	30/8388	0.709480140607888	0.984896383253138	0.905777283213412	ALDOB	1
hsa05206	MicroRNAs in cancer	11/338	310/8388	0.711541847507614	0.984896383253138	0.905777283213412	CYP1B1/ERBB3/SOCS1/ITGB3/ABCB1/RECK/MIRLET7I/MIR126/MMP9/MIR103A1/TGFB2	11
hsa05169	Epstein-Barr virus infection	7/338	202/8388	0.711644242099802	0.984896383253138	0.905777283213412	JUN/GADD45B/HLA-A/GADD45G/IRF7/TNF/MAPK10	7
hsa05415	Diabetic cardiomyopathy	7/338	203/8388	0.716448206636398	0.984896383253138	0.905777283213412	PLCB4/ACE/PRKCZ/MMP9/MAPK10/TGFB2/CPT1B	7
hsa05310	Asthma	1/338	31/8388	0.721228849925253	0.984896383253138	0.905777283213412	TNF	1
hsa05222	Small cell lung cancer	3/338	92/8388	0.723267104420356	0.984896383253138	0.905777283213412	GADD45B/GADD45G/NOS2	3
hsa00310	Lysine degradation	2/338	63/8388	0.728008571964131	0.984896383253138	0.905777283213412	PRDM7/PIPOX	2
hsa03250	Viral life cycle - HIV-1	2/338	63/8388	0.728008571964131	0.984896383253138	0.905777283213412	MAP1A/CXCR4	2
hsa04215	Apoptosis - multiple species	1/338	32/8388	0.732503786951131	0.984896383253138	0.905777283213412	MAPK10	1
hsa00051	Fructose and mannose metabolism	1/338	33/8388	0.743324002366464	0.984896383253138	0.905777283213412	ALDOB	1
hsa04932	Non-alcoholic fatty liver disease	5/338	155/8388	0.754727304408637	0.984896383253138	0.905777283213412	JUN/SOCS3/CEBPA/TNF/MAPK10	5
hsa04060	Cytokine-cytokine receptor interaction	10/338	295/8388	0.757581473570364	0.984896383253138	0.905777283213412	IL6ST/GDF9/CSF2/IL13RA1/TNFRSF11A/CXCR4/TNF/TGFB2/CXCR6/TNFRSF25	10
hsa05231	Choline metabolism in cancer	3/338	98/8388	0.762031337841706	0.984896383253138	0.905777283213412	JUN/PLA2G4B/MAPK10	3
hsa00040	Pentose and glucuronate interconversions	1/338	35/8388	0.763672682371877	0.984896383253138	0.905777283213412	DCXR	1
hsa00230	Purine metabolism	4/338	128/8388	0.764424883327712	0.984896383253138	0.905777283213412	ADCY6/ENTPD2/GUCY1B1/PDE6C	4
hsa00830	Retinol metabolism	2/338	68/8388	0.7660620561474	0.984896383253138	0.905777283213412	DGAT1/LRAT	2
hsa00564	Glycerophospholipid metabolism	3/338	99/8388	0.768046375229444	0.984896383253138	0.905777283213412	PLA2G4B/LPCAT1/PLAAT2	3
hsa04061	Viral protein interaction with cytokine and cytokine receptor	3/338	100/8388	0.773937323897999	0.984896383253138	0.905777283213412	IL6ST/CXCR4/TNF	3
hsa05230	Central carbon metabolism in cancer	2/338	70/8388	0.779943025739204	0.984896383253138	0.905777283213412	FGFR1/NTRK1	2
hsa04914	Progesterone-mediated oocyte maturation	3/338	102/8388	0.785352366846511	0.984896383253138	0.905777283213412	ADCY6/PRKACA/MAPK10	3
hsa04137	Mitophagy - animal	2/338	72/8388	0.793098479923659	0.984896383253138	0.905777283213412	JUN/MAPK10	2
hsa04625	C-type lectin receptor signaling pathway	3/338	104/8388	0.79628773284347	0.984896383253138	0.905777283213412	JUN/TNF/MAPK10	3
hsa03008	Ribosome biogenesis in eukaryotes	5/338	164/8388	0.796672225102552	0.984896383253138	0.905777283213412	SNORD3A/RNA5-8SN3/SNORD3B-1/RNA5-8SN5/RNA5-8SN4	5
hsa01524	Platinum drug resistance	2/338	73/8388	0.799412764310593	0.984896383253138	0.905777283213412	GSTT2B/GSTT2	2
hsa04115	p53 signaling pathway	2/338	73/8388	0.799412764310593	0.984896383253138	0.905777283213412	GADD45B/GADD45G	2
hsa00513	Various types of N-glycan biosynthesis	1/338	39/8388	0.799670481322361	0.984896383253138	0.905777283213412	CHST8	1
hsa04630	JAK-STAT signaling pathway	5/338	166/8388	0.805188902036967	0.984896383253138	0.905777283213412	SOCS1/IL6ST/SOCS3/CSF2/IL13RA1	5
hsa00260	Glycine, serine and threonine metabolism	1/338	40/8388	0.807780599577606	0.984896383253138	0.905777283213412	PIPOX	1
hsa03010	Ribosome	5/338	167/8388	0.809340495385965	0.984896383253138	0.905777283213412	RNA5-8SN3/RPL36A/RPL3L/RNA5-8SN5/RNA5-8SN4	5
hsa03320	PPAR signaling pathway	2/338	75/8388	0.811531816035777	0.984896383253138	0.905777283213412	LPL/CPT1B	2
hsa04623	Cytosolic DNA-sensing pathway	2/338	75/8388	0.811531816035777	0.984896383253138	0.905777283213412	IRF7/MEFV	2
hsa05214	Glioma	2/338	75/8388	0.811531816035777	0.984896383253138	0.905777283213412	GADD45B/GADD45G	2
hsa03440	Homologous recombination	1/338	41/8388	0.815563320869265	0.984896383253138	0.905777283213412	TOP3B	1
hsa04216	Ferroptosis	1/338	41/8388	0.815563320869265	0.984896383253138	0.905777283213412	SAT2	1
hsa04066	HIF-1 signaling pathway	3/338	109/8388	0.821606801966412	0.988008179579863	0.908639101441869	ALDOB/EGLN3/NOS2	3
hsa00071	Fatty acid degradation	1/338	43/8388	0.830198759696647	0.989985968675918	0.91045800997342	CPT1B	1
hsa04975	Fat digestion and absorption	1/338	43/8388	0.830198759696647	0.989985968675918	0.91045800997342	DGAT1	1
hsa05017	Spinocerebellar ataxia	4/338	143/8388	0.834295115888191	0.990725450117227	0.911138087088419	PLCB4/GRIN2C/GRIN3B/MAPK10	4
hsa00983	Drug metabolism - other enzymes	2/338	80/8388	0.839019188007693	0.992201114448932	0.912495207748048	GSTT2B/GSTT2	2
hsa01200	Carbon metabolism	3/338	115/8388	0.848411240762842	0.993158048200321	0.913375268705005	ALDOB/IDH3A/GPT2	3
hsa04072	Phospholipase D signaling pathway	4/338	148/8388	0.853383946817684	0.993158048200321	0.913375268705005	GRM3/ADCY6/PLCB4/PLA2G4B	4
hsa04662	B cell receptor signaling pathway	2/338	84/8388	0.858344464834658	0.993158048200321	0.913375268705005	JUN/CD72	2
hsa04722	Neurotrophin signaling pathway	3/338	119/8388	0.864278809782853	0.993158048200321	0.913375268705005	JUN/NTRK1/MAPK10	3
hsa04145	Phagosome	4/338	152/8388	0.867285511448854	0.993158048200321	0.913375268705005	ACTG1/HLA-A/ITGB3/COLEC12	4
hsa04672	Intestinal immune network for IgA production	1/338	49/8388	0.867514357792055	0.993158048200321	0.913375268705005	CXCR4	1
hsa05014	Amyotrophic lateral sclerosis	11/338	364/8388	0.875120409011338	0.993158048200321	0.913375268705005	NEFL/NEFM/ACTG1/RAB39B/DNAH3/GRIN2C/PFN4/NUP210L/TNF/NOS2/HAP1	11
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	2/338	89/8388	0.879517756805295	0.993158048200321	0.913375268705005	JUN/ALK	2
hsa04150	mTOR signaling pathway	4/338	156/8388	0.880043609765674	0.993158048200321	0.913375268705005	FZD9/FZD8/WNT5A/TNF	4
hsa05160	Hepatitis C	4/338	157/8388	0.883062545751765	0.993158048200321	0.913375268705005	CLDN5/SOCS3/IRF7/TNF	4
hsa00600	Sphingolipid metabolism	1/338	53/8388	0.887726620035447	0.993158048200321	0.913375268705005	NEU1	1
hsa05320	Autoimmune thyroid disease	1/338	53/8388	0.887726620035447	0.993158048200321	0.913375268705005	HLA-A	1
hsa03460	Fanconi anemia pathway	1/338	54/8388	0.892279517747267	0.993158048200321	0.913375268705005	TOP3B	1
hsa04142	Lysosome	3/338	132/8388	0.906209270361843	0.993158048200321	0.913375268705005	DMXL2/NEU1/LAPTM4B	3
hsa04650	Natural killer cell mediated cytotoxicity	3/338	132/8388	0.906209270361843	0.993158048200321	0.913375268705005	HLA-A/CSF2/TNF	3
hsa04666	Fc gamma R-mediated phagocytosis	2/338	97/8388	0.907409355172163	0.993158048200321	0.913375268705005	MARCKSL1/PLA2G4B	2
hsa04714	Thermogenesis	6/338	232/8388	0.911536393661755	0.993158048200321	0.913375268705005	ADCY6/ACTG1/PRKACA/FGFR1/ADRB3/CPT1B	6
hsa04151	PI3K-Akt signaling pathway	10/338	354/8388	0.911874185456657	0.993158048200321	0.913375268705005	ERBB3/GNG8/ITGB3/FGF22/FGFR1/GNB5/NTRK1/AREG/ITGA9/GNG3	10
hsa04370	VEGF signaling pathway	1/338	59/8388	0.912426501548736	0.993158048200321	0.913375268705005	PLA2G4B	1
hsa04510	Focal adhesion	5/338	203/8388	0.91724244355872	0.993158048200321	0.913375268705005	JUN/ACTG1/ITGB3/ITGA9/MAPK10	5
hsa05164	Influenza A	4/338	171/8388	0.918872916305594	0.993158048200321	0.913375268705005	ACTG1/SOCS3/IRF7/TNF	4
hsa05022	Pathways of neurodegeneration - multiple diseases	14/338	476/8388	0.918932702901839	0.993158048200321	0.913375268705005	NEFL/NEFM/FZD9/PLCB4/RAB39B/DNAH3/GRIN2C/FZD8/WNT5A/TNF/MAPK10/TPTEP2-CSNK1E/NOS2/HAP1	14
hsa00140	Steroid hormone biosynthesis	1/338	62/8388	0.922662364940009	0.993158048200321	0.913375268705005	CYP1B1	1
hsa04140	Autophagy - animal	3/338	141/8388	0.927978110494901	0.993158048200321	0.913375268705005	PRKACA/RAB39B/MAPK10	3
hsa04120	Ubiquitin mediated proteolysis	3/338	142/8388	0.930087594650154	0.993158048200321	0.913375268705005	SOCS1/UBE2D1/SOCS3	3
hsa05152	Tuberculosis	4/338	180/8388	0.936381596724927	0.993158048200321	0.913375268705005	TNF/MAPK10/TGFB2/NOS2	4
hsa00010	Glycolysis / Gluconeogenesis	1/338	67/8388	0.937139612142039	0.993158048200321	0.913375268705005	ALDOB	1
hsa05208	Chemical carcinogenesis - reactive oxygen species	5/338	223/8388	0.950151889031714	0.993158048200321	0.913375268705005	CYP1B1/JUN/GSTT2B/GSTT2/MAPK10	5
hsa00562	Inositol phosphate metabolism	1/338	73/8388	0.950989680070743	0.993158048200321	0.913375268705005	PLCB4	1
hsa05010	Alzheimer disease	10/338	384/8388	0.951416404421405	0.993158048200321	0.913375268705005	FZD9/PLCB4/GRIN2C/FZD8/WNT5A/TNF/MAPK10/LPL/TPTEP2-CSNK1E/NOS2	10
hsa04110	Cell cycle	3/338	157/8388	0.955614675712977	0.993158048200321	0.913375268705005	GADD45B/GADD45G/TGFB2	3
hsa04152	AMPK signaling pathway	2/338	121/8388	0.959065506915024	0.993158048200321	0.913375268705005	FOXO1/CPT1B	2
hsa04721	Synaptic vesicle cycle	1/338	78/8388	0.960175338698748	0.993158048200321	0.913375268705005	UNC13B	1
hsa01521	EGFR tyrosine kinase inhibitor resistance	1/338	79/8388	0.961795162467679	0.993158048200321	0.913375268705005	ERBB3	1
hsa03018	RNA degradation	1/338	79/8388	0.961795162467679	0.993158048200321	0.913375268705005	BTG1	1
hsa01232	Nucleotide metabolism	1/338	85/8388	0.970223791432709	0.995597935775159	0.915619154230894	ENTPD2	1
hsa04114	Oocyte meiosis	2/338	131/8388	0.971144653142085	0.995597935775159	0.915619154230894	ADCY6/PRKACA	2
hsa05150	Staphylococcus aureus infection	1/338	96/8388	0.981154599241227	0.999457114203856	0.919168315555901	SELP	1
hsa04070	Phosphatidylinositol signaling system	1/338	97/8388	0.981922778866946	0.999457114203856	0.919168315555901	PLCB4	1
hsa03013	Nucleocytoplasmic transport	1/338	108/8388	0.988566640357965	0.99981428088255	0.919496790174533	NUP210L	1
hsa01240	Biosynthesis of cofactors	1/338	153/8388	0.998256446030059	0.99981428088255	0.919496790174533	MOCS1	1
hsa05016	Huntington disease	4/338	306/8388	0.998674719547565	0.99981428088255	0.919496790174533	PLCB4/DNAH3/MAPK10/HAP1	4
hsa04740	Olfactory transduction	7/338	439/8388	0.999128001831396	0.99981428088255	0.919496790174533	PRKACA/SLC8A3/OR13G1/OR2AG2/RGS2/OR11H7/OR6B2	7
hsa05012	Parkinson disease	2/338	266/8388	0.99981428088255	0.99981428088255	0.919496790174533	PRKACA/MAPK10	2
